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Abstract 
This entry reviews the structure, function and 
clinical significance of YEATS4, a gene originally 
identified from an amplicon on 12p15 found in a 
glioblastoma cell line and originally named glioma-
amplified sequence (GAS41). The gene is amplified 
in several other cancers and translocations or 
rearrangements of chromosome 12 with breakpoints 
in YEATS4 are noted in such cancers as 
glioblastoma, lung cancer and soft tissue sarcomas. 
Several frameshift and one nonsense mutations have 
also been detected in cancer. As the YEATS4 protein 
is involved in chromatin modeling, transcriptional 
regulation and mitotic regulation, such aberrations 
are likely to deregulate cellular mechanisms 
involved in the normal control of cellular 
proliferation and cell death. 
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Identity 
Other names 
Gas41, NuBI1, YAF9 
HGNC (Hugo) 
YEATS4 
Location 
12q15; Extends between Chromosome 12: 
69,359,703-69,390,796, (according to hg38-Dec 
2013)(Fig. 1) 
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Fig. 1. Location of the YEATS4 gene is shown within a 500kb region of 12p15. A) Protein-coding genes; B) 
Genes for non-coding and microRNAs; C) Processed pseudogenes. 
 
 
 
 
DNA/RNA 
 
Fig. 2. Genomic structure of YEATS4. The exon distributions for the two alternatively spliced products (RefSeq 
accessions NM_006530 and NM_001300950 are shown, with the intron sizes given in base pairs (bp). Coding 
regions are shown in thicker lines; non-coding regions (5' untranslated and 3' untranslated regions) are depicted 
as thinner lines. 
 
Description 
YEATS4 is encoded by 7 exons spread over 
31,094bp (Fig. 2). The gene encodes two 
alternatively spliced products (RefSeq accessions 
NM_006530 and NM_001300950). Transcript 1 
(NM_006530) is 1501 nucleotides in length and 
encodes a protein of 227 amino acids. Transcript 2 
(NM_001300950) is 1339 nucleotides long and 
encodes a protein of 173 amino acids. 
Protein 
 
Fig. 3. Structure of the YEATS4 protein. Location of exon boundaries (vertical lines) are shown relative to the 
protein structure. The YEATS and Coiled domains are involved in the functional interactions of the protein. 
Alternative splicing removes exon 3 and 4, yielding transcript 2, such that isoform 2 (NP_001287879) misses 55 
amino acids of the YEATS domain. 
 
Description 
The YEATS4 transcripts produce two proteins; 
isoform 1 is 227 amino acids long (RefSeq 
accession: NP_006521) and isoform 2 is 173 amino 
acids long (RefSeq accession: NP_001287879). 
Isoform 1 has two defined structural/functional 
features: the YEATS domain located between amino 
acid residue 44 and 123, and a coiled coiled domain 
(amino acid 168 - ter). The YEATS domain is 
conserved in YNK7 (Yaf9), MLLT1 (ENL), MLLT3 
(AF-9) and the TFIIF small subunit. Yaf9 in S. 
cerevisiae is a subunit of the NuA4 histone 
acetyltransferase complex (Le Masson et al., 2003). 
Thus, the YEATS domain is thought to be involved 
in transcriptional regulation. A C-terminal coiled 
coil domain interacts with several proteins indicated 
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below and is critical for incorporation of YEATS4 
into the human TIP60 complex (Park and Roeder 
2006). Six chemical modifications have been 
annotated in the Prosite database on amino acids 
conserved between human and mouse (Fig. 4), four 
of which are ubiquitinylation of lysines located in the 
coiled coil domain (Hornbeck et al., 2014). Fifty five 
amino acids of the YEATS domain are missing from 
isoform 2. 
 
Fig. 4. Location of chemically modified amino acid side chains. Amino acid residues positions are given relative 
to NP_006521. Key: p- phosphorylation, ac- acetylation, ub- ubiquitination. 
 
Expression 
Northern blot analysis detects a ubiquitously 
expressed transcript of approximately 1.7kb, with 
high expression in brain, heart and skeletal muscle 
(Harbroth et al., 2000). In general, RNA-seq analysis 
consistently indicates highest expression in the 
testes, tissues of the immune system (bone marrow, 
lymph node and thymus) and the brain, specifically 
the cerebellum (Fagerberg et al., 2013; Duff et al., 
2015; GTEx Portal 2017). 
Localisation 
Several articles indicate that YEATS4 is located in 
punctate structures in the nucleoplasm of the 
interphase nucleus of the majority of tested cells, 
including glioblastoma cell lines (Harborth et al., 
2000; Munnia et al., 2001; Debernardi et al., 2002; 
Lauffart et al., 2002). However, YEATS4 is 
localized to nucleoli in the neuroblastoma cell lines 
SK-N-SH, Neuro 2a, and NS20 (Munnia et al., 
2001), suggesting a possible functional 
differentiation for YEATS4 in tumors of the 
peripheral compared to central nervous system. 
Function 
Based on its homology with Yaf 9 (by what is now 
called the YEATS domain [Fig. 1]), YEATS4 was 
predicted to be a subunit of the human homologue of 
the NuA4 histone acetyltransferase complex, the 
Tip60 complex. This complex is involved in gene 
regulation and the repair of double-stranded DNA 
breaks. This multisubunit complex has histone 
H4/H2A acetyltransferase activity, is capable of 
ATP-dependent H2AZ -H2B histone dimer 
exchange, and has DNA helicase activity (Auger et 
al., 2008). YEATS4 is also a subunit of the SNP2-
related CBP activator protein ( SRCAP) complex, 
which is a distinct complex also involved in the 
exchange of Histone H2A for H2Z in chromatin, 
although the complex functions without 
acetyltransferase activity (Auger et al., 2008). 
YEATS4 also directly interacts with SWI/SNF 
component SMARCB1 (BAF47 or INI1) 
(Debernardi et al., 2002), MLLT10, which is a 
histone lysine methyltransferase DOT1L cofactor 
(Debernardi et al., 2002), the KDM1A demethylase 
(Piccinni et al., 2011), and the TFIIF component 
GTF2F2 (RAP30) (Heisel et al., 2010). It has been 
suggested that the YEATS domain acts as an 
evolutionarily conserved chromatin modification 
reader, and possibly directly binds to histones 
(Schulze et al., 2010). 
Further evidence for a function of YEATS4 in 
transcription has come from direct interactions with 
transcription factor TFAP2A (AP-2) (Ding et al., 
2006), and the C-terminal region of the myc family 
members MYCN and MYC (Piccinni et al., 2011), 
identified by affinity capture techniques such as 
yeast two-hybrid analysis, GST-pull down and 
coimmunoprecipitation. The β-catenin gene 
(CTNNB1) is regulated by binding of YEATS4 to its 
promoter, either via these transcription factors, or in 
combination with the chromatin modeling 
complexes discussed above (Ji et al., 2017; Jixiang 
et al., 2017). Downstream targets of β-catenin such 
as CCND1 (Cyclin D1), CDK4, CDK6 and c-Myc, 
and the apoptotic proteins BCL2 and BAX also 
respond to overexpression and decreased expression 
of YEATS4 in gastric cancer and pancreatic cancer 
(Ji et al., 2017; Jixiang et al., 2017). 
As noted above, the Tip60 and SCRAP complex play 
roles in double-stranded DNA repair. However, 
YEATS4 is involved in the regulation of DNA repair 
independent of these complexes. YEATS4 
overexpression results in destabilization of TP53, 
with downregulation of YEATS4 leading to 
stabilization of p53 with concomitant upregulation 
of p53 target genes such as CDKN1A (p21), and 
induction of senescence and apoptosis (Llanos et al., 
2006; Park et al., 2006; Pikor et al., 2013; Tao et al., 
2015). Furthermore, overexpression of YEATS4 
increases resistance of normal bronchial epithelial 
cells to the platinum drug cisplatin and p53- MDM2 
interaction inhibitor, nutlin (Pikor et al., 2013). 
Mechanistically, YEATS4 acts with PP2Cβ to 
dephosphorylate ser-366 on p53, and can decrease 
cell death due to UV-induced DNA damage (Park et 
al., 2011). Thus, overexpression of YEATS4 may 
contribute to the cancers described below in part by 
overcoming the tumor suppressor properties of p53. 
Additional functions of YEATS4 in nuclear 
architecture and regulation of mitotic spindle 
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assembly were uncovered shortly after its discovery. 
Harborth et al., (2000) performed yeast two-hybrid 
analysis to identify proteins that bind to the C-
terminus (amino acids 1048-2115) of NUMA1 
(NuMA). Further mapping indicated that YEATS4 
bound via its coiled coil domain to the C-terminal 
region of the coiled-coil rod domain of NuMA 
(amino acids 1048-1700). This interaction was 
confirmed independently by co-
immunoprecipitation, Dot Overlay Assays, Surface 
Plasmon Resonance, and by a separate study 
(Munnia et al., 2001). Later studies showed that 
interaction between NuMA and YEATS4 was cell-
cycle regulated with the interaction being low in G1 
to S, increasing in S phase and being maximal at 
G2/M (Schmitt et al., 2012). NuMA is a nuclear 
matrix protein that relocalizes to and anchors 
microtubules to the spindle poles (reviewed in Haren 
et al., 2009). Manipulation of the expression of 
YEATS4 and NuMA via expression plasmids and 
siRNA results in an increased rate of spindle defects 
leading to multipolar spindles and misaligned 
chromosomes (Schmitt et al., 2012). Additional 
interactions of YEATS4 with CEP162 (Munnia et 
al., 2001), and TACC1 - TACC2 - TACC3 (Lauffart 
et al., 2002; Lauffart et al., 2003), proteins with 
known roles in centrosomal dynamics during mitosis 
(Gergley et al., 2000a,b; Leon et al., 2006), have also 
been identified. However, even these YEATS4-
interacting proteins have been implicated in 
transcriptional regulation. For instance, during 
interphase NuMA binds to and acts as a 
transcriptional coregulator of p53 upon DNA-
damage (Endo et al., 2013; Ohata et al., 2013); 
CEP162 associates with predominantly nuclear 
localized KAT14 lysine acetyltransferase (Gupta et 
al., 2015; Wang et al., 2008); and the TACC proteins 
bind to nuclear localized histone acetyltransferases 
(Gangisetty et al., 2004), nuclear hormone receptors 
(Vettaikkorumakankauv et al., 2008; Guyot et al., 
2010; Hein et al., 2015; Huttlin et al., 2017) and 
other transcription factors (Sadek et al., 2000; 
Simpson et al., 2004); Bargo et al., 2010), and 
coregulate their transcriptional targets. 
YEATS4 has been found in complexes with a further 
108 proteins by high-throughput analysis via affinity 
purification-mass spectrometry (Li et al., 2015; 
Huttlin et al., 2015; Huttlin et al., 2017). Many of 
these interactions support the proposed functions of 
YEATS4 in the TIP60 and SCRAP complexes, 
transcriptional regulation, and mitotic regulation. 
For instance, additional transcription factors of 
relevance to cancer, such as FOS, Fox family 
members, and the myc partner MAX have been 
identified as YEATS4-binding factors (Li et al., 
2015). 
Homology 
The YEATS domain is highly conserved within 
eukaryotes and defines a family of proteins involved 
in key functions including transcriptional regulation 
and chromatin structure (see above). Four YEATS 
family members are found in humans (MLLT1 
[ENL], MLLT3 [AF9], YEATS2, and YEATS4). A 
BLASTp search of the protein database can identify 
a defined YEATS4 protein in metazoan eukaryotes 
representing fungi, arthopods, cnirdarians, and 
chordates, but not plants. In S. cerevisiae, Yaf9 has 
been proposed to be the closest functional homolog 
to YEATS4, containing both the YEATS domain 
and the C-terminal coiled coil region (Le Masson et 
al., 2003). The Yaf9 protein shows 33% amino acid 
identity and 57% homology to human YEATS4. The 
N-terminal YEATS domain of YEATS4 is able to 
functionally interchange with that of Yaf9 (Piccinni 
et al., 2011). 
Mutations 
Somatic 
A total of 39 somatic sequence variations 
involving the coding region of YEATS4 are 
recorded in COSMIC v81, released 09-May-17, 
at http://cancer.sanger.ac.uk/cosmic 
(Bamford et al., 2004; Forbes et al., 2017). Of 
those, seven are silent, twenty-seven are 
missense, four are frameshifts, and one is a 
nonsense mutation. Each sequence variant 
has been found in a single case, except for 
G75D which was detected in 3 colon cancer 
cell lines HCT8, HCT15, DLD1. c.63C>T, 
c.66T>G, c.333T>C, c.475C>T, c.498T>C, 
c.680_681insA are noted as single nucleotide 
polymorphisms in the dSNP database 
(https://www.ncbi.nlm.nih.gov/SNP/snp_ref.c
gi?locusId=8089). 
). 
Position 
(AA) 
Mutation (CDS) 
Mutation (Amino 
Acid) 
Mutation 
Type 
Cancer type 
2 c.6C>G p.F2L s.m. Rectal adenocarcinoma 
YEATS4 (YEATS domain containing 4)  
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8 c.22T>C p.F8L s.m. Hepatocellular carcinoma 
10 c.28C>T p.P10S s.m. Stomach adenocarcinoma 
21 c.63C>T# p.I21I s.s Malignant melanoma 
22 c.66T>G# p.V22V s.s Clear cell renal cell carcinoma 
35 c.103G>A p.G35R s.m. Thyroid carcinoma 
43 c.127C>T p.H43Y s.m. Malignant melanoma 
43 c.124delG p.H43fs*9 d.fs. Lung adenocarcinoma 
52 c.156A>G p.K52K s.s. Stomach adenocarcinoma 
58 c.172G>C p.D58H s.m. Lung adenocarcinoma 
75 c.224G>A p.G75D s.m. Colon 
78 c.234A>G p.L78L s.s Lung carcinoma 
93 c.279G>T p.W93C s.m. 
Primitive neuroectodermal tumour - 
medulloblastoma 
95 c.284A>C p.E95A s.m. Papillary renal cell carcinoma 
97 c.289G>A p.E97K s.m. Rectal Adenocarcinoma 
100 c.300C>G p.I100M s.m. Pancreatic ductal carcinoma 
110 c.328A>G p.R110G s.m. Malignant melanoma 
111 c.333T>C# p.P111P s.s Adenocarcinoma of Large intestine 
125 c.375C>A p.T125T s.s Malignant melanoma 
133 c.398C>G p.T133R s.m. Clear cell renal cell carcinoma 
136 c.407C>T p.S136L s.m. Malignant melanoma 
141 c.421G>T p.E141* s.n. Endometrioid carcinoma 
147 c.438delC p.P147fs*4 d.fs. Breast Ductal carcinoma 
150 c.449T>C p.M150T s.m. Pancreas Ductal carcinoma 
151 c.453G>A p.M151I s.m. Liver neoplasm 
154 c.461T>C p.L154S s.m. Head neck Squamous cell carcinoma 
159 c.475C>T# p.R159C s.m. Malignant melanoma 
162 c.485C>T p.T162I s.m. Papillary renal cell carcinoma 
163 c.489A>C p.L163F s.m. Breast Carcinoma 
YEATS4 (YEATS domain containing 4)  
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166 c.498T>C# p.Y166Y s.s. Head neck Squamous cell carcinoma 
170 c.509C>G p.T170R s.m. Basal (triple-negative) carcinoma 
174 c.521A>C p.E174A s.m. Breast Phyllodes tumour 
180 c.539G>C p.R180T s.m. Lung Adenocarcinoma 
192 c.575T>C p.F192S s.m. Stomach Intestinal adenocarcinoma 
207 c.619A>T p.T207S s.m. Central nervous system Oligodendroglioma 
207 c.619delA p.T207fs*2 d.fs. Endometrium Serous carcinoma 
208 c.624A>G p.I208M s.m. Hepatocellular carcinoma 
224 c.671C>T p.A224V s.m. Breast Ductal carcinoma 
228 c.680_681insA# p.*228fs? i.fs. Breast Carcinoma 
Table 1: Sequence variations tabulated from COSMIC v81 (accessed 7/25/2017). KEY: d.fs. - deletion leading to 
frameshift; i.fs. - insertion leading to frameshift; s.m. - missense substitutions; s.s. - silent substitution; s.n. - 
nonsense substitution; # variants recorded as single nucleotide polymorphisms. Cells in green denote variations 
located in the YEATS domain, and cells in blue denote variations located in the C-terminal coiled coil domain. 
 
Implicated in 
The YEATS4 gene is located in a region of 
Chromosome 12 that is subject to genomic 
instability and amplification in several different 
cancers. 117 of 508 human cancer cell lines (23%) 
exhibited copy number gains of YEATS4 (Pikor et 
al., 2015). Fusion genes have been identified by 
RNA-seq analysis of the samples in the Cancer 
Genome Atlas, as well as in other tumor samples. As 
many rearrangements resulting in fusions between 
YEATS4 and other coding genes are found in the 
same region of the long arm of chromosome 12 that 
is also subject to amplification, they may be the 
result of intrachromosomal inversions or deletions. 
However, as the mechanism of the rearrangements is 
unclear, the genomic alterations will be designated 
as translocations for the purpose of this review. 
Bladder urothelial carcinoma 
RNA-seq analysis of 414 bladder urothelial 
carcinomas, detected one rearrangement, 
t(12;12)(q15;q15), fusing exon 4 of YEATS4 out-of-
frame to exon 2 of the human lysozyme (LYZ) gene 
(Yoshihara et al., 2015). Presumably non-sense 
mediated decay would prevent significant protein 
product accumulating. 
YEATS4 (YEATS domain containing 4)  
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Fig. 5. Hybrid gene and protein produced by t(12;12)(q15;q15). With a breakpoint located in intron 4 of 
YEATS4 and intron 1 of LYZ, RNA-seq detected an out-of-frame fusion gene that could only produce a 
significantly truncated YEATS4 protein. 
Brain cancer 
YEATS4 was identified as an amplified sequence 
(GAS41) in glioblastoma multiforme (GBM) cell 
line TX3868, with amplification subsequently noted 
at higher frequency in lower grade astrocytoma 
grades I and II. (Fischer et al., 1997). In a larger 
study by Schmitt et al. (2012) of 258 glioblastoma 
samples from the Cancer Genome Atlas. 9 
glioblastomas had high level of YEATS4 
amplification. However, 26.1% of the samples 
exhibited reduced expression. 
Four genomic rearrangements involving YEATS4 
have been noted in glioblastoma. Frattini et al. 
(2013) performed RNA-sequencing of 161 primary 
GBM and 24 short-term glioma sphere cultures. 
These authors detected a single rearrangement 
t(12;12)(q14.1;q15), resulting in a fusion between 
YEATS4 and XRCC6BP1 (X-ray repair cross-
complementation group 6 binding protein 1). 
XRCC6BP1 (AKA ATP23) is involved in double-
stranded DNA break repair (Fischer et al., 2013) and, 
based on homology via its metalloprotease domain, 
is suggested to be important in the biosynthesis of 
mitochondrial ATPase (Zeng et al., 2007). The 
detected transcript indicates that the fusion protein 
contains the YEATS domain fused to the majority of 
the peptidase M76 domain of XRCC6BP1 (missing 
20 amino acids at the N-terminus) (Fig. 6). 
 
Fig. 6. Hybrid gene and protein produced by t(12;12)(q14.1;q15) that fuses YEATS4 exon 6 to exon 3 of 
XRCC6BP1. The Mitelman database contains records generated from paired-end whole genome-sequencing of 
YEATS4 (YEATS domain containing 4)  
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42 paired TCGA glioblastoma tumors and matching normal samples (Zheng et al., 2013, Yoshihara et al., 2015). 
A translocation t(12;12)(q15;q24) resulting in an in-frame fusion between YEATS4 exon 4 and exon 33 of 
EP400 (Fig. 7) was reported in the Mitelman database, however this fusion is absent from the TUMOR FUSION 
GENE DATA PORTAL developed by the same authors (http://54.84.12.177/PanCanFusV2/), and may not have 
survived further validation. The YEATS4-EP400 hybrid protein would contain contains 111 amino acids of 
YEATS4, containing part of the YEATS domain fused to the C-terminal 1811 amino acids of EP400, containing 
the SNF2 family domain and DNA_pol3_delta2 super family domain (cl26247). Yoshihara et al (2015) detected 
one case of a t(12;12)(q13.3;q15), generating an out-of-frame fusion of YEATS4 exon 6 to methionyl-tRNA 
synthetase ( MARS) exon 12 (Fig. 8). If the fusion protein is produced from the initiator methionine of YEATS4, 
the protein would be 187 amino acids long and contain the YEATS domain. However, one might predict that 
nonsense-mediated decay may reduce the accumulation of the fusion mRNA, and subsequent protein. A larger 
RNA-seq analysis followed by sequencing of 185 GBM samples from TCGA and Ivy center cohort also detected 
a fusion between YEATS4 (exon 1) and exon 4 of SLC35E3 located 601kb centromeric (Shah et al., 2013). 
While the fusion RNA detected would be driven from the YEATS4 promoter, the 106 amino acid fusion protein 
would only contain part of the triose phosphate transporter domain of SLC35E3 (Fig. 9). While it is possible that 
the fusion could inhibit the function of any normal YEATS4 or SLC35E3 protein in the tumor cell, it would 
seem more likely that the reciprocal product, if produced, would be of functional significance. However, the 
reciprocal SLC35E3-YEATS4 fusion transcript was not recorded. 
Fig. 7. Fusion between exon 4 of YEATS4 and exon 33 of EP400 (numbering based on NM_015409 and protein 
NP_056224). The fusion protein is 1922 amino acids long. Domain Key: Y: YEATS domain; cc: Coiled coil 
domain; EP400_N: pfam15790, E1A-binding protein p400, N-terminal domain is characterized by low-
complexity but its function is unknown; Atroph: Atrophin-1 super family domain, a polyglutamine stretch may 
interact with histone acetytransferase CBP; HSA: domain found in helicases and associated with SANT 
domains; SNF2_N: SNF2 family N-terminal domain; SNF: SNF2 family domain; DN: DNA_pol3_delta2 super 
family domain (cl26247). 
 
Fig. 8. Out-of-frame fusion between YEATS4 and MARS. The hybrid gene could produce a truncated YEATS4 
protein missing the coiled coil domain. Domain Key: Y: YEATS domain; cc: Coiled coil domain; GST: 
Glutathione S-transferase C-terminal-like, alpha helical domain of Methionyl-tRNA synthetase from higher 
eukaryotes; PRK12267 super family domain: Methionyl-tRNA synthetase. 
Fig. 9. Hybrid gene and protein produced by t(12;12)(q15;q15) that fuses YEATS4 exon 1 to exon 4 of 
SLC35E3. SLC35E3 encodes a protein of 313 amino acids (NP_061126) and is identified as a member of the 
triose-phosphate transporter (TPT) family based upon a central 278 amino acid domain. 
 
Colorectal carcinoma 
In a study of 86 colorectal carcinoma patients, 
increased expression (> 4th quartile) of YEATS4 
correlated with decreased survival HR = 1.910, 95% 
CI: 1.005-3.632, P = 0.048 (Tao et al., 2015).  
 
One rearrangement involving YEATS4 was detected 
in a study of 95 rectal adenocarcinomas by RNA-seq 
analysis and recorded in the TUMOR FUSION 
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GENE DATA PORTAL. The rearrangement is 
identical to that observed in hepatocellular 
adenocarcinoma, fusing YEATS4 exon 6 to the final 
(noncoding exon) of CPSF6 (Fig. 11). Thus, the 
predicted fusion protein contains a truncated 
YEATS4 coding sequence contain the YEATS 
domain, but lacking the C-terminal coiled coil 
domain. 
Gastric Cancer 
Quantitative real time reverse transcriptase PCR 
analysis of 30 Gastric cancers by Ji et al. (2017) 
detected increased expression of the YEATS4 
transcript compared to normal adjacent tissue. 13% 
of samples showed decreased expression. 
Overexpression of YEATS4 mRNA and protein was 
associated with cancer stage, with highest expression 
observed in Stage III gastric cancer. Overall survival 
and disease-free survival was decreased with high 
expression of YEATS4 (Ji et al., 2017). The authors 
detected increased occupancy of the beta-catenin 
promoter by the YEATS4 protein, leading to histone 
acetylation and increased transcription of the beta 
catenin gene.  
 
One case of a t(12;12)(q15;q15) fusing exon 6 of 
YEATS4 to exon 2 of the human lysozyme gene 
(LYZ) was identified from 414 cases in the Tumor 
Fusion Gene Data Portal. The resulting fusion 
protein contains the YEATS domain and the 
hydrolytic catalytic cleft of lysozyme. This 
rearrangement is identical to that detected in liver 
hepatocarcinoma cancer (see Fig. 10). 
Hypertension 
The SNP rs7297610, located between YEATS4 and 
FRS2, was associated with antihypertensive 
response to hydrochlorothiazide. Specifically, the 
C/C genotypes was associated with significant 
improvement in blood pressure in treated African 
Americans. Baseline YEATS4 expression was 
increased in peripheral blood of C/C genotype 
individuals, but decreased upon treatment with 
hydrochlorothiazide (Duarte et al., 2013). 
Liposarcoma 
Amplification and overexpression of YEATS4 
occurs in liposarcomas (Italiano et al., 2008; 
Barretina et al., 2010; Creytens et al., 2015). In a 
study of 28 well-differentiated liposarcomsas and 10 
dedifferentiated liposarcomas, Italiano et al., (2008) 
subdivided the 12q13-15 amplicon into three 
independent amplicons. One amplicon, centered on 
MDM2 in 12q15 often contained YEATS4 with 
concomitant increased expression of the gene. A 
larger study of 77 lipomatous soft tissue tumors 
(including lipomas, well-differentiated liposarcomas 
(WDLPS), dedifferentiated liposarcomas (DDLPS) 
and pleomorphic liposarcomas) found that 
amplification of the YEATS4 gene was more 
frequent and at a higher level in dedifferentiated 
liposarcomas than in well-differentiated 
liposarcomas (Creytens et al., 2015). Knockdown of 
YEATS4 by shRNA in dedifferentiated liposarcoma 
independently reduced cell proliferation suggesting 
that YEATS4 acts as a driver gene within the 12q15 
amplicon (Barretina et al., 2010). 
Liver hepatocellular carcinoma 
Two rearrangements involving YEATS4 have been 
detected in a study of 374 hepatocellular. carcinomas 
by RNA-seq analysis and recorded in the TUMOR 
FUSION GENE DATA PORTAL (2017). One case 
of a t(12;12)(q15;q15) fusing exon 6 of YEATS4 to 
exon 2 of the human lysozyme gene (LYZ) was 
identified. The resulting fusion protein contains the 
YEATS domain and the hydrolytic catalytic cleft of 
lysozyme (Fig. 10). This rearrangement is identical 
to that detected in stomach cancer (see below). The 
second rearrangement involves CPSF6 (cleavage 
and polyadenylation specific factor 6), located 
101kb centromeric to YEATS4 (Fig. 1), and fuses 
exon 6 to the final, noncoding, exon of CPSF6 (Fig. 
11). Thus, the fusion protein would be a truncated 
YEATS4 coding sequence containing the YEATS 
domain, but lacking the C-terminal coiled coil 
domain. The rearrangement is identical to that 
detected in rectal adenocarcinoma (see below). 
YEATS4 (YEATS domain containing 4)  
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Fig. 10. Fusion between YEATS4 and LYZ, with a breakpoint located in intron 6 of YEATS4 and intron 2 of 
LYZ. The resulting fusion gene produces a fusion protein containing the YEATS domain and the Lysozyme 
catalytic cleft (LCC). 
 
Fig. 11. The CPSF6 protein (NP_0008938) is coded by the first 9 exons of the CPSF6 transcript (NM_007007). 
CPSF6 has one conserved domain (RRM_CFIm68) defined as a 'RNA recognition motif of pre-mRNA cleavage 
factor Im 68 kDa subunit (CFIm68 or CPSF6) and similar protein'. The 4846 base pair tenth exon is untranslated, 
thus the fused hybrid gene produces a truncated YEATS4 protein. 
 
Lung cancer 
Pikor et al., (2015) performed gene expression and 
copy number analysis of 261 non-small cell lung 
cancers (NSCLC) relative to matched normal 
tissues. The 432 kb region encompassing LYZ to 
BEST3 (Fig. 1) (and RAB3IP located telomeric to 
BEST3) was amplified in 20% of the samples tested. 
Of the 7 genes within the amplicon, only YEATS4 
was both gained/amplified and concomitantly 
overexpressed in lung tumors with YEATS4 
amplified in 18% (47/261) and overexpressed in 
31% (15/48) of tumor samples originally tested. 
YEATS4 copy gain/amplification was detected in an 
additional 43/128 (33.6%) lung cancer cell lines. 
YEATS4 was overexpressed in 18% (15/83) of the 
Early Detection Research Network samples and 33% 
(14/42) from the Cancer Genome Atlas. 3/83 tumors 
showed higher amplification of YEATS4 compared 
to the MDM2 protooncogene, that is the main 
suspected driver of 12q15 amplification, suggesting 
that YEATS4 can provide an independent advantage 
over MDM2 in some lung cancers. The study 
validated overexpression of the YEATS4 protein in 
15/59 (25.4%) tumors and 8/18 (44.4%) NSCLC cell 
lines. Knockdown of YEATS4 in cell lines 
containing YEATS4 amplification induced 
senescence and apoptosis in a p53/p21 mediated 
manner. Overexpression of YEATS4 increased 
resistance of normal bronchial epithelial cells to the 
platinum drug cisplatin and p53-MDM2 interaction 
inhibitor, nutlin (Pikor et al., 2015). 
The TUMOR FUSION GENE DATA PORTAL 
(2017) reports one case of a t(12;12)(q15;q15) from 
541 Lung adenocarcinomas, involving YEATS4 and 
SLC35E3. The rearrangement fuses YEATS4 (exon 
4) to exon 4 of SLC35E3 resulting in part of the 
YEATS domain to 65 amino acids of the triose 
phosphate transporter domain (Fig. 12). 
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Fig. 12. In-frame fusion between YEATS4 and SLC35E3. SLC35E3 encodes a protein of 313 amino acids 
(NP_061126) and is identified as a member of the triose-phosphate transporter (TPT) family based upon a 
central 278 amino acid domain. The YEATS4-SLC35E3 fusion protein contains 111 amino acids of YEATS4 
fused to 88 amino acids of the SLC35E3 protein containing the C-terminal 65 amino acids of the triose 
phosphate transporter domain. 
 
Müllerian adenosarcomas of the 
uterus 
In an analysis of 15 uterine and one ovarian 
Müllerian adenosarcomas, five cases showed 
amplification of a 900kb region stretching from 
SLC35E3 to BEST3, and thereby encompassing the 
YEATS4 locus on 12q15 (Lee et al., 2016). 
Pancreatic cancer 
YEATS4 transcript overexpression was noted in 31 
pancreatic cancer samples relative to adjacent non-
cancerous tissues (Jixiang et al., 2017). An 
expansion of this study to 93 pancreatic samples in 
the ONCOMINE database (Rhodes et al., 2004) 
further indicated clinical significance of YEATS4 
expression in pancreatic cancer. Introduction of 
YEATS4 into a normal pancreatic epithelial cell 
lines promote growth invasion and motility. These 
effects were mediated, at least in part, by activation 
of the Wnt pathway and direct interaction with beta 
catenin (Jixiang et al., 2017). 
Soft tissue Sarcomas (unclassified) 
Five translocations were identified by Verhaak and 
colleagues from 263 Sarcomas and reported in the 
TUMOR FUSION GENE DATA PORTAL (2017). 
The adult sarcomas are unclassified in the National 
Cancer Institute Genomic Data Commons Data 
Portal. Each translocation fuses YEATS4 3' prime to 
its fusion partner. 
One case t(1;12)(q21.3;q15) fuses the exon 4 of 
KCNN3 (potassium calcium-activated channel 
subfamily N member 3)(based on transcript 
NM_002249) in-frame to exon 2 of YEATS4. The 
fusion protein would be 740 amino acids long and 
contain the calcium-activated SK potassium channel 
domain and part of the ion channel domain 
(pfam03530 and pfam07885) from KCNN3 and the 
YEATS4 YEATS domain and coiled coil domain 
(Fig. 13). 
In a different tumor, another in-frame fusion occurs 
between exon 2 of MARCH9 on 12q14.1 and exon 2 
of YEATS4 (Fig. 14). MARCH9 is a member of the 
MARCH family of membrane-bound E3 ubiquitin 
ligases. The fusion protein product is 380 amino 
acids long, containing the C4HC3 zinc-finger like 
RING domain and the YEATS4 YEATS domain and 
coiled coil domain. 
The other three translocations observed fuse 
YEATS4 exon 7 out of frame 3-prime to its fusion 
partner, suggesting that these rearrangements 
produce a truncated protein lacking any YEATS4 
components. One case of t(1;12)(q24.2;q15) fuses 
exon 16 of a coactivator of ligand-dependent nuclear 
receptors, DCAF6, to exon 7 of YEATS4 (Fig. 15). 
A truncated protein would contain the WD40 and 
cl26247 (DNA polymerase III, delta subunit) 
domains involved in transcriptional regulation, but 
miss the final 200 amino acids of the coactivator. A 
single t(12;12)(q21.1;q15) fuses exon 1 of the THAP 
domain containing, apoptosis associated protein 2 ( 
THAP2) out-of-frame to exon 7 of YEATS4. The 
"fusion' protein would also be truncated, and only 
contain the first 24 amino acids of the THAP2 
protein, and 5 amino acids encoded out of frame 
from exon 7 of YEATS4 (Fig. 16). The last case 
noted was an out of frame fusion between exon 10 of 
TMTC1 and exon 7 of YEATS4 
t(12;12)(p11.22;q15). If the truncated 564 amino 
acid 'fusion' protein is produced, it would lack the C-
terminal tetratricopeptide repeats of TMTC1 (Fig. 
17). 
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Fig. 13. In-frame fusion between KCNN3 and YEATS4. Exon numbering for KCNN3 is based upon transcript 
NM_002249 that codes for isoform a (NP_002240). Key: Y: YEATS domain; CC: coiled coil domain; SK_C: 
calcium-activated SK potassium channel domain; I_T2: Ion Transporter_2 (ion channel) domain; CM: 
Calmodulin binding domain; Grey box: Prefoldin super family domain structure. 
Fig. 14. The MARCH9 gene contains 4 exons and encodes a transcript (NM_138396) of 2985 nucleotides, with 
a 5' untranslated region of 431 nucleotides and a 3' untranslated region of 1517 nucleotides. The full length 
MARCH9 protein is 346 amino acids long (NP_612405). The fusion between exon 2 of MARCH9 and exon 2 of 
YEATS4 could produce a fusion peptide of 380 amino acids. 
Fig. 15. The DCAF6 gene contains 22 exons and encodes multiple alternatively splice transcripts. Protein 
Isoform b (NP_001017977) was selected as the canonical form by UniProtKB, coded by a transcript 2 
(NM_001017977) of 3360 nucleotides, with a 5' untranslated region of 353 nucleotides and a 3' untranslated 
region of 1064 nucleotides. This transcript is missing exon 11, 12, and 17. W: WDR11 repeat region. 
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Fig. 16. The THAP2 gene contains 3 exons and encodes a transcript of 4840 nucleotides, with a 5' untranslated 
region of 613 nucleotides and a 3' untranslated region of 3959 nucleotides. The full length THAP2 protein is 228 
amino acids long (NP_113623), containing the DNA binding THAP domain. The fusion between exon 1 of 
THAP2 and exon 7 of YEATS could produce a fusion peptide of only 29 amino acids in size. 
Fig. 17. The TMTC1 mRNA is encoded by 18 exons and is 8.75kb long with a 3' untranslated region of 6.2kb. 
The full length TMTC1 protein (NP_001180380) is 882 amino acid long and contains two domains: the 
DUF1736 (D) and the TPR-11 domain. The TMTC1-YEATS4 fusion gene would produce a 2468 nucleotide 
mRNA encoding 559 amino acids of TMTC1, missing the C-terminal 323 amino acid region containing most of 
the tetratricopeptide repeats of the TPR-11 domain. 
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